← Back to Search

Arm 2 for Bowel Incontinence

N/A
Waitlist Available
Led By Felix W Leung, MD
Research Sponsored by US Department of Veterans Affairs
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up the primary outcome will be determined at the end of the study which will be 20 weeks after starting the study.
Awards & highlights

Summary

The purpose of this study is to determine if a behavioral treatment method called biofeedback will reduce the frequency of episodes of leakage of fecal material in patient suffering from fecal incontinence.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~the secondary outcome will be determined at the end of the study which will be 20 weeks after starting the study.
This trial's timeline: 3 weeks for screening, Varies for treatment, and the secondary outcome will be determined at the end of the study which will be 20 weeks after starting the study. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Patient Report of "Adequate Relief" From FI Symptoms With a "Yes" Answer Will be Used as Variable. Data Will be Recorded at End of Treatment. A "Responder" Will be Defined as One Who Provides a "Yes" Answer.
Secondary outcome measures
Change in Anorectal Physiologic Tests (Absolute Squeeze Pressure)

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Arm 2Experimental Treatment1 Intervention
Study group of patients with fecal incontinence which would be given biofeedback therapy and exercises to perform as treatment.
Group II: Arm 1Active Control1 Intervention
Control group of patients with fecal incontinence which would be given medical therapy and exercises to perform as treatment.

Find a Location

Who is running the clinical trial?

US Department of Veterans AffairsLead Sponsor
872 Previous Clinical Trials
497,982 Total Patients Enrolled
Felix W Leung, MDPrincipal InvestigatorVA Greater Los Angeles Healthcare System, Sepulveda, CA
3 Previous Clinical Trials
1,968 Total Patients Enrolled
~0 spots leftby Sep 2025